July 11 (Reuters) - The U.S. Food and Drug Administration has declined to approve Ultragenyx Pharmaceutical's ( RARE ) experimental gene therapy to treat a rare inherited disorder, citing manufacturing concerns, the company said on Friday. The therapy, UX111, was developed to treat Sanfilippo syndrome type A - a rare, inherited disorder that begin in early childhood causing severe brain...

04:48 PM EDT, 07/11/2025 (MT Newswires) -- Marc Benioff, Director, Chair and CEO, on July 10, 2025, sold 2,250 shares in Salesforce ( CRM ) for $598,854. Following the Form 4 filing with the SEC, Benioff has control over a total of 22,062,566 common shares of the company, with 11,955,566 shares held directly and 10,107,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1108524/000112760225019093/xslF345X05/form4.xml...

04:46 PM EDT, 07/11/2025 (MT Newswires) -- Richard D Campbell, 10% Owner, on July 09, 2025, sold 300,000 shares in Vital Energy ( VTLE ) for $5,469,188. Following the Form 4 filing with the SEC, Campbell has control over a total of 7,568,933 common shares of the company, with 7,568,933 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1528129/000177446325000004/xslF345X05/primary_doc.xml ...

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...